1. Rheumatoid Arthritis Treatment Options and Type 2 Diabetes: Unravelling the Association

   • Claudia Di Muzio
   • Paola Cipriani
   • Piero Ruscitti

   Leading Article Open access 02 November 2022 Pages: 673 - 685

   

2. Localised Delivery of Macromolecules to the Large Intestine: Translation to Clinical Trials

   • David J. Brayden

   Leading Article 25 October 2022 Pages: 687 - 700

   

3. Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Potential Biodrug for Acute Respiratory Distress Syndrome Treatment

   • Hao Sun
   • Tianyuan Zhang
   • Jianqing Gao

   Review Article 10 September 2022 Pages: 701 - 715

   

4. Non-small Cell Lung Cancer with EGFR or HER2 Exon 20 Insertion Mutations: Diagnosis and Treatment Options

   • Danielle Brazel
   • Gianna Kroening
   • Misako Nagasaka

   Review Article Open access 18 October 2022 Pages: 717 - 729

5. Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine

   • Johanna Elin Gehin
   • Guro Løvik Goll
   • Silje Watterdal Syversen

   Review Article Open access 31 October 2022 Pages: 731 - 748

   

6. Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial

   • Claire Verschraegen
   • Zoran Andric
   • Yuichiro Ohe

   Original Research Article Open access 28 September 2022 Pages: 749 - 760

   

7. Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Aspart (MYL-1601D) Compared with Originator Insulin Aspart (Novolog^®) in Patients with Type 1 Diabetes After 24 Weeks: A Randomized Open-Label Study

   • Thomas C. Blevins
   • Yaron Raiter
   • Abhijit Barve

   Original Research Article Open access 17 September 2022 Pages: 761 - 772

   

8. The Economic Burden of CAR T Cell Therapies Ciltacabtagene Autoleucel and Idecabtagene Vicleucel for the Treatment of Adult Patients with Relapsed or Refractory Multiple Myeloma in the US

   • Buthainah Ghanem
   • Lu Shi

   Original Research Article 27 September 2022 Pages: 773 - 780

   

9. Lower Limbs are the Most Difficult-to-Treat Body Region of Patients with Psoriasis: Pooled Analysis of CLEAR and CLARITY Studies of Secukinumab Versus Ustekinumab by Body Region

   • Miguel Alpalhão
   • Joana Duarte
   • Paulo Filipe

   Original Research Article 05 November 2022 Pages: 781 - 789

   

10. Correction: Immunotherapy in Gastro-Oesophageal Cancer: Current Practice and the Future of Personalised Therapy

    • Mary E. Booth
    • Elizabeth C. Smyth

    Correction 15 October 2022 Pages: 791 - 791